A clinical research study is being conducted to see if
Aricept changes attention and concentration
Qualified participants must:
- Be diagnosed with mild to moderate Alzheimer’s disease
- Be about to start Aricept as recommended by a physician
- Have no current or prior use of Aricept or similar AD medications (other types of medications are allowed)
If you qualify for participation, you will receive monetary compensation and two months of free medication.
For more information, please contact Lori Hoggard at Queens College/CUNY – 718-997-3219.
|
